MCRB Competitors & Alternatives
Compare Seres Therapeutics Inc with similar stocks in the same industry
Biotechnology
MCRB
Main Stock$2.17
Tradestie Score
49
Market Cap
$179.47M
Revenue Growth
-0.9%
Analyst Upside
+685.2%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.22
|
$154.27M | - | 60 | Compare |
|
FATE
Fate Therapeutics, Inc.
|
$2.08
|
$144.16M | - | 56 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.71
|
$133.50M | - | 67 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.54
|
$114.01M | - | 67 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$23.16
|
$110.20M | - | 71 | Compare |
|
MGNX
MacroGenics, Inc.
|
$3.59
|
$107.45M | - | 60 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.03
|
$84.52M | - | 39 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.33
|
$67.94M | - | 63 | Compare |
|
KPTI
Karyopharm Therapeutics Inc.
|
$0.53
|
$53.85M | - | 43 | Compare |
|
SYRS
SYRS
|
- | - | - | - | Compare |
More MCRB Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry